Abstracts tagged "quality of life and rheumatoid arthritis (RA)"

Abstract Number: PP04 • 2018 ACR/ARHP Annual Meeting
Improved Quality of Life with Patient Engagement in Research
Kelly English¹ and Graham Macdonald², ¹Arthritis Patient Advisory Board, Arthritis Research Canada, Richmond, BC, Canada, ²Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada
Background/Diagnosis: I am a woman, 60 years old who has lived with difficult-to-treat Rheumatoid Arthritis for 23 years. When first diagnosed with RA, there were…
Abstract Number: 296 • 2018 ACR/ARHP Annual Meeting
Does Care By a Multidisciplinary Team Improve Outcomes in Rheumatoid Arthritis? a Randomized Controlled Study
Manjari Lahiri^1,2, Peter P.M. Cheung^1,2, Preeti Dhanasekaran², Su Ren Wong³, Ai Yap³, Daphne Tan³, Amelia Santosa^1,2 and Phillip HC Phan², ¹Division of Rheumatology, University Medicine Cluster, National University Hospital, Singapore, Singapore, Singapore, ²Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, ³Department of Rehabilitation, National University Hospital, Singapore, Singapore, Singapore
Background/Purpose: Quality standards recommend an annual review by a multidisciplinary team (MDT) for all patients with rheumatoid arthritis (RA); however, this is based on expert…
Abstract Number: 349 • 2018 ACR/ARHP Annual Meeting
Improving the Performance of the Spanish Version of QOL-RA
Carolina Ayelen Isnardi¹, Dafne Capelusnik², Emilce E Schneeberger³, María de los Angeles Correa⁴, Romina Lim⁵, María Hu⁵, María Janina Tapia⁶, Eduardo Mario Kerzberg⁷, Eliana Soledad Blanco⁸, Federico Lujan Benavidez⁸, Luciana Gonzalez Lucero⁹, Ana Lucia Barbaglia⁹, Marcela Bazzarelli¹⁰, Hernán Maldonado Ficco¹¹, Silvana Karina Pérez¹², Claudia Hartvig¹³, Mariana Salcedo¹⁴ and Gustavo Citera¹⁵, ¹Reumatology, Instituto de Rehabilitación Psicofísica, CABA, Argentina, ²Reumatology, Instituto de Rehabilitación Psicofísica, Argentina, CABA, Argentina, ³Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁴Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁵Reumatology, Hospital Penna, CABA, Argentina, ⁶Reumatology, Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina, ⁷Department of Rheumatology, Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina, ⁸Reumatology, Hospital General de Agudos Dr. Cosme Argerich, CABA, Argentina, ⁹Hospital Angel C. Padilla, Tucuman, Argentina, ¹⁰Reumatology, Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina, ¹¹Rheumatology Section, Hospital San Antonio de Padua, Río Cuarto- Córdoba, Argentina, ¹²Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, CABA, Argentina, ¹³Rheumatology Section, Hospital Provincial de Rosario, Rosario-Santa Fe, Argentina, ¹⁴Reumatology, San Nicolás, Buenos Aires, Argentina, ¹⁵Rheumatology Section, Instituto de Rehabilitación Psicofísica, CABA, Argentina
Background/Purpose: We have recently validated the Quality of Life-Rheumatoid Arthritis Scale (QOL-RA). Redundancy between questions Nº 3 and Nº 6 was observed, and it was…
Abstract Number: 1387 • 2018 ACR/ARHP Annual Meeting
Fatigue in Patients with Rheumatoid Arthritis As Compared to Different Groups of Cancer Patients
Jens Gert Kuipers¹, Michael Koller², Ulrich Rueffer³, Florian Zeman², Karolina Mueller⁴ and Joachim Weis⁵, ¹Clinic for Internal Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, ²Center of Clinical Studies, University Hospital Regensburg, Regensburg, Germany, ³German Fatigue Society, Cologne, Germany, ⁴Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, ⁵University Clinic Centre Freiburg, Freiburg, Germany
Background/Purpose: Fatigue is a common symptom in patients with rheumatoid arthritis (RA) as well as patients with cancer. Fatigue considerably reduces the quality of life…
Abstract Number: 1525 • 2018 ACR/ARHP Annual Meeting
Effect of JAK-Inhibitor Versus Bdmards on Quality of Life in Rheumatoid Arthritis : A Meta Analysis of Randomized Controlled Trials
Mamadaly Boudhabhay¹, Thomas Barnetche² and Pascale Vergne-Salle³, ¹CHU de Limoges, Limoges, France, ²Rheumatology Department, FHU ACRONIM, Bordeaux University Hospital, Bordeaux, France, ³Rheumatology, CHU de Limoges, Limoges, France
Background/Purpose: Recent studies comparing JAK-inhibitors (Jak-i) and adalimumab seem to show a better efficacy of JAK-i on patient-reported outcomes in rheumatoid arthritis (RA). As there…
Abstract Number: 1555 • 2018 ACR/ARHP Annual Meeting
Quality of Life of Rheumatoid Arthritis Patients Treated with Biologics
Sonia Tropé¹, Gérard Thibaud², Françoise Alliot³, Didier Formont⁴ and Sadek Krouri⁵, ¹149 avenue du Maine, ANDAR, Paris, France, ²ANDAR patient organisation, Paris, France, ³AFLAR, Paris, France, ⁴A+A Healthcare Market Research, BOULOGNE, France, ⁵Public affair & Advocacy Rheumatology, Sanofi, Gentilly, France
Background/Purpose: Major advances in the management of rheumatoid arthritis (RA) have been recorded over the last decade thanks to the introduction of biologics. However, medical…
Abstract Number: 2482 • 2018 ACR/ARHP Annual Meeting
The Use of Any Conventional Synthetic DMARD Is Associated with Better Indexes of the Physical Component Evaluated By 12-Item Short-Form Health Survey : Analysis of a Cohort of RA Patients
Alisson Pugliesi¹, Eduardo de Almeida Macedo², Manoel Barros Bertolo³, Rina Dalva Neubarth Giorgi⁴, Sebastião Radominski⁵, Ivânio Alves Pereira⁶, Maria Fernanda Brandao de Resende Guimarães⁷, Paulo Louzada Junior⁸, Maria de Fátima da Cunha Sauma⁹, Karina Bonfiglioli¹⁰, Claiton Brenol¹¹, Lícia M. H. Mota¹² and Geraldo Castelar Pinheiro¹³, ¹INTERNAL MEDICINE, DISCIPLINE OF RHEUMATOLOGY, University of Campinas (UNICAMP), CAMPINAS, Brazil, ²Internal Medicine, University of Campinas (UNICAMP), Campinas, Brazil, ³University of Campinas (UNICAMP), Campinas, Brazil, ⁴Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil, ⁵Unversidade Federal do Paraná, Curitiba, Brazil, ⁶Universidade Federal de Santa Catarina, Florianópolis, Brazil, ⁷Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, ⁸Universidade de São Paulo - Ribeirão Preto, Ribeirão Preto, Brazil, ⁹Universdade Federal do Pará, Belém, Brazil, ¹⁰Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, ¹¹Rua Cabral, 764 – Apto 302, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, ¹²Hospital Universitário de Brasília - UnB, Brasília, Brazil, ¹³Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
Background/Purpose: Patients with rheumatoid arthritis (RA) report a reduction in quality of life (QoL) in several aspects when compared to the healthy population. QoL can…
Abstract Number: 2220 • 2017 ACR/ARHP Annual Meeting
Neuropathic-like Pain Affects the Tender Joint Count and Health-Related Quality of Life in Patients with Rheumatoid Arthritis
Kentaro Noda¹, Miku Tajima², Yosuke Oto³, Kazuhiro Otani³, Yoshiga Masayuki³, Haruyasu Ito¹, Ken Yoshida¹ and Daitaro Kurosaka¹, ¹Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan, ²Division of Rheumatology, Department of Internal Medecine, Jikei University School of Medicine, Tokyo, Japan, ³Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
Background/Purpose: Pain in rheumatoid arthritis (RA) has been thought to be due to nociceptive pain, but it was reported recently to include a mechanism associated…
Abstract Number: 2244 • 2017 ACR/ARHP Annual Meeting
Can Achieving Remission Improve Work Ability and Quality of Life in Early Rheumatoid Arthritis (RA) Patients? a Prospective Cohort Study
Ho Man Lam¹, Tsz Ho CHENG² and Lai-Shan Tam¹, ¹Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ²Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Background/Purpose: RA patients often suffer from impaired work ability and reduced health related quality of life (HRQoL). Whether achieving remission through tight-control treatment strategy using…
Abstract Number: 2254 • 2017 ACR/ARHP Annual Meeting
Disability (HAQ) and Quality of Life (SF-12) As Related to Adherence and Health Literacyin Patients with Rheumatoid Arthritis – the Trace-Study
Jens Gert Kuipers¹, Michael Koller², Florian Zeman², Karolina Mueller² and Jens Ulrich Rueffer³, ¹Department of Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, ²University Hospital Regensburg, Center for Clinical Studies, Regensburg, Germany, ³German Fatigue Society, Cologne, Germany
Background/Purpose: Disabilities in daily living and quality of life are key endpoints to evaluate the outcome of treatment for rheumatoid arthritis (RA). Among factors that…
Abstract Number: 642 • 2016 ACR/ARHP Annual Meeting
Quality of Life Outcomes Following Therapy with Chs-0214 and Etanercept (Enbrel): Randomized, Double-Blind Study in Subjects with Rheumatoid Arthritis
Alan J. Kivitz^1,2, James R. O'Dell³, Tsutomu Takeuchi⁴, Yoshiya Tanaka⁵, Satoshi Nakashima⁶, Cass Kelleher⁷, Jennifer Hodge⁸, Barbara Finck⁷ and RApsody Study Group, ¹Altoona Center for Clinical Research, Duncansville, PA, ²Altoona Arthritis & Osteoporosis Center, Duncansville, PA, ³Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ⁴Division of Rheumatology, Department of Internal Medicine,, Keio University School of Medicine, Tokyo, Japan, ⁵The First Department of Internal Medicine,, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, ⁶Daiishi Sankyo, Shinagawa-Ku Tokyo, Japan, ⁷Clinical Science, Coherus BioSciences, Redwood City, CA, ⁸Coherus BioSciences, Redwood City, CA
Background/Purpose: CHS-0214 is in development as a proposed biosimilar of etanercept. This Phase III confirmatory, safety and efficacy study randomized and dosed 644 subjects with…
Abstract Number: 1158 • 2016 ACR/ARHP Annual Meeting
Effects of an Educational Program Using Treat to Target Strategy in Korean Patients with Rheumatoid Arthritis
SeungIn Paek¹, Seo Hwa Kim², Haneul Kim³, Min Kyung Chung⁴, Jennifer Lee⁵, Seung-Ki Kwok⁶, Ji Hyeon Ju⁷, Sung-Hwan Park⁷ and Kyeong Yae Sohng⁸, ¹Center for Rheumatic Diseases, Seoul ST Mary's Hospital, The Catholic University of Korea, Seoul, South Korea, ²Division of Rheumatology,, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, ³Division of Rheumatology,, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Republic of Korea, Seoul, Korea, The Republic of, ⁴Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, ⁵Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea, ⁶[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, ⁷Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, ⁸College of Nursing, The Catholic University of Korea, Seoul, South Korea
Background/Purpose: The purpose of this study was to investigate the effects of an educational program using T2T (Treat RA to Target, T2T) strategy on Korean…
Abstract Number: 1231 • 2016 ACR/ARHP Annual Meeting
Impact of Comorbidity on Health-Related Quality of Life and Healthcare Expenditure in Patients with Rheumatoid Arthritis
Eric Nyarko¹ and J An², ¹College of Pharmacy, Western University of Health Sciences, Pomona, CA, ²Western University of Health Sciences, Pomona, CA
Background/Purpose: Rheumatoid Arthritis (RA) is known to be associated with an increased risk of comorbidity, premature mortality, and disability. We investigated the effect of comorbidity…
Abstract Number: 2346 • 2016 ACR/ARHP Annual Meeting
The Improving Motivation for Physical Activity in Arthritis Clinical Trial for Adults with Knee Osteoarthritis and Rheumatoid Arthritis
Abigail Gilbert¹, Julia (Jungwha) Lee², Pamela Semanik³, Jing Song⁴, Christine Pellegrini⁵, Daniel Pinto⁶, Dorothy D. Dunlop⁴, Rowland W. Chang⁷ and Linda S. Ehrlich-Jones⁸, ¹Northwestern University Feinberg School of Medicine, Chicago, IL, ²Preventive Medicine/Biostatistics, Northwestern University Feinberg School of Medicine, Chicago, IL, ³College of Nursing, Rush University, Chicago, IL, ⁴Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁵Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Department of Physical Therapy & Human Movement Sciences, Northwestern University, Chicago, IL, ⁷Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁸Research CROR, Rehabilitation Institute Chicago, Chicago, IL
Abstract: Background/Purpose: Insufficiently active adults experience reduced quality of life. Because half of adults with arthritis are physically inactive, we evaluated the additional effect of…
Abstract Number: 377 • 2016 ACR/ARHP Annual Meeting
Pain and Quality of Life Profiles in Colombian Patients with Rheumatoid Arthritis: A Mixed Cluster Analysis
Juan Manuel Cotte¹, Nicolás Molano-González², Deisy Hernández-Parra³, Yenifer Delgado-Scarpetta³, Adriana Rojas-Villarraga², Juan-Manuel Anaya¹ and Ricardo Pineda-Tamayo³, ¹Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogotá, Colombia, ²Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogotá D.C., Colombia, ³Artmédica IPS, Medellin, Colombia, Medellin, Colombia
ABSTRACT Background/Purpose: Among the symptoms of Rheumatoid Arthritis (RA), pain is often regarded as a critical factor related to quality of life (QoL) by patients,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].